Exicure, Inc. (XCUR)


-0.06 (-7.67%)
Symbol XCUR
Price $0.7202
Beta 1.136
Volume Avg. 0.03M
Market Cap 6.229M
Shares () -
52 Week Range 0.63-1.96
1y Target Est -
DCF Unlevered XCUR DCF ->
DCF Levered XCUR LDCF ->
ROE 40.04% Strong Buy
ROA 20.27% Buy
Operating Margin -
Debt / Equity 72.12% Buy
P/E 0.42 Neutral
P/B 0.63 Buy


Consensus EPS

Upgrades & Downgrades

Latest XCUR news

Mr. Paul Kang
NASDAQ Capital Market

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.